Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma
Michils, A.; Sternon, J.
Journal de Pharmacie de Belgique 61(3): 83-87
2006
ISSN/ISBN: 0047-2166 PMID: 17058881 Document Number: 597864
Omalizumab (Xolair) is the first representative of a new therapeutical class for severe allergic asthma. By neutralizing Ac IgE, omalizumab fulfils an anti-inflammatory action of which the effect has been shown beneficial in the treatment of severe allergic asthma and particularly in severe asthma for which the therapeutical arsenal is for the time being disappointing and associated to frequent side effects there where omalizumab is well tolerated.
Document emailed within 1 workday
Related Documents
Nolte, H.; Harving, H.; Backer, V. 2007: Treatment of severe asthma with anti-immunoglobulin e (Omalizumab). a new possibility in pulmonary medicine Ugeskrift for Laeger 169(50): 4366-4367Domingo, C.; Pomares, X.; Angril, N.; Rudi, N.; Amengual, M.J.; Mirapeix, R.M. 2013: Effectiveness of omalizumab in non-allergic severe asthma Journal of Biological Regulators and Homeostatic Agents 27(1): 45-53
Sposato, B.; Scalese, M.; Milanese, M.; Masieri, S.; Cavaliere, C.; Ricci, A.; Paggiaro, P. 2018: Should omalizumab be used in severe asthma/COPD overlap? Journal of Biological Regulators and Homeostatic Agents 32(4): 755-761
Qiu, X.; Wang, H. 2015: Research progress of monoclonal antibody omalizumab in the treatment of allergic rhinitis Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(2): 166-168
Casale, T.B. 2004: Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis Drugs of Today 40(4): 367-376
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Tsuji, T.; Kimura, Y.; Murakami, T.; Sasaki, K.; Shinozaki, F. 1990: An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231 Gan no Rinsho. Japan Journal of Cancer Clinics 36(7): 783-786
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Yalcin, A.D.; Reginald M Gorczynski; Parlak, G.E.; Kargi, A.; Bisgin, A.; Sahin, E.; Kose, S.; Gumuslu, S. 2012: Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment Clinical Laboratory 58(1-2): 89-96
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C. 2010: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 795-798
Pisetsky, D.S.; Hoch, S.O.; Klatt, C.L.; O'Donnell, M.A.; Keene, J.D. 1985: Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity Journal of Immunology 135(6): 4080-4085
Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Juhl, H.; Sievers, M.; Baltzer, K.; Helmig, F.; Wolf, H.; Brenner, W.; Kalthoff, H. 1995: A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach Cancer Research 55(23 Suppl): 5749s-5755s
Chattopadhyay, P.; Kaveri, S.V.; Byars, N.; Starkey, J.; Ferrone, S.; Raychaudhuri, S. 1991: Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1 Cancer Research 51(22): 6045-6051
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Berger, W.E. 2000: Clinical trials results of a unique monoclonal antibody in asthma Allergie et Immunologie 32(9): 333-335
Pisetsky, D.S.; Semper, K.F.; Eisenberg, R.A. 1984: Idiotypic analysis of a monoclonal anti-Sm antibody. II. Strain distribution of a common idiotypic determinant and its relationship to anti-Sm expression Journal of Immunology 133(4): 2085-2089